Top Markets
#1 Black Phoenix Black Phoenix +166.18%
#2 Islamic Coin Islamic Coin +158.21%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.80%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.53%
#6 MarsCoin MarsCoin +13.34%
#7 Test Test +12.58%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +11.52%
#9 Palladium Network Palladium Network +9.76%
#10 Useless Coin Useless Coin +9.21%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Vaxxinity, Inc. Vaxxinity, Inc.

Vaxxinity, Inc.

VAXX
Classifica tra le azioni #41692
Vaxxinity, Inc., a biotechnology company founded in 2014 and headquartered in... Vaxxinity, Inc., a biotechnology company founded in 2014 and headquartered in Dallas, Texas, is dedicated to advancing novel therapeutic candidates for human application in the United States. Its primary areas of focus are neurological disorders and infectious diseases, particularly those caused by coronaviruses. The company's pipeline features several key programs: UB-311 is a Phase 2 clinical trial candidate targeting toxic aggregated amyloid-beta proteins in the brain, aiming to treat Alzheimer's disease. UB-312, currently in Phase 1 clinical trials, is an investigational therapy designed to address Parkinson's disease and other synucleinopathies, including Lewy body dementia and multiple system atrophy, by targeting detrimental aggregated alpha-synuclein. An anti-tau product candidate is also under development for various neurodegenerative conditions, such as Alzheimer's disease. UB-313 is being developed to alleviate migraines by modulating calcitonin gene-related peptide. An anti-PCSK9 candidate aims to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events by targeting proprotein convertase subtilisin/kexin type 9 serine protease. In the infectious disease segment, UB-612 is a Phase 3 clinical-stage candidate engineered to neutralize the SARS-CoV-2 virus.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$12.68K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-99.76%
Paese
US
Scambia Vaxxinity, Inc. (VAXX)

Categoria

Healthcare
Il prezzo VAXX con la capitalizzazione del mercato della B
Vaxxinity, Inc. Vaxxinity, Inc.
VAXX
$0.0001
Capitalizzazione di mercato di Vaxxinity, Inc.(VAXX)
Capitalizzazione di mercato: $12.68K
A partire dal August 2026, Vaxxinity, Inc. ha una capitalizzazione di mercato pari a $12.68K. Questo rende Vaxxinity, Inc. la 41692nd azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Vaxxinity, Inc. dal 2021 al 2026
VAXX in paragone con la classifica dei più popolari stocks
Il prezzo per VAXX Attivo B Capitalizzazione del mercato a B Risultati
Vaxxinity, Inc. Vaxxinity, Inc.
$42,462.21 $12.68K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +42,462,213,656.11%
Vaxxinity, Inc. Vaxxinity, Inc.
$34,890.29 $12.68K
Apple Inc. Apple Inc.
AAPL
$4.423T +34,890,291,773.62%
Vaxxinity, Inc. Vaxxinity, Inc.
$32,815.66 $12.68K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +32,815,660,091.53%
Vaxxinity, Inc. Vaxxinity, Inc.
$28,895.10 $12.68K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +28,895,100,365.37%
Vaxxinity, Inc. Vaxxinity, Inc.
$22,805.09 $12.68K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +22,805,085,839.42%